Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J. Birkett

Showing results (81-90 of 127) with videos related to

Pageof 13
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1995
Human hepatic cytochrome P450 2C9 catalyzes the rate-limiting pathway of torsemide metabolismJ O Miners, D L Rees, L Valente, et al.
The Medical Journal of Australia|December 1, 1979
Availability of schedule 3 preparations from community pharmaciesJ W Ilic, P R Saloniklis, J Hughes, et al.
British Journal of Clinical Pharmacology|January 3, 2001
The xenobiotic inhibitor profile of cytochrome P4502C8C E Ong, S Coulter, D J Birkett, et al.
British Journal of Clinical Pharmacology|February 1, 1997
1-Methylxanthine derived from caffeine as a pharmacodynamic probe of oxypurinol effectD J Birkett, J O Miners, L Valente, et al.
Biochemical Pharmacology|December 3, 1993
Validation of 4-nitrophenol as an in vitro substrate probe for human liver CYP2E1 using cDNA expression and microsomal kinetic techniquesW Tassaneeyakul, M E Veronese, D J Birkett, et al.
British Journal of Clinical Pharmacology|August 1, 1986
Influence of gender and oral contraceptive steroids on the metabolism of salicylic acid and acetylsalicylic acidJ O Miners, N Grgurinovich, A G Whitehead, et al.
Biochemistry|October 17, 1989
Structural and functional analysis of NADPH-cytochrome P-450 reductase from human liver: complete sequence of human enzyme and NADPH-binding sitesM Haniu, M E McManus, D J Birkett, et al.
The Medical Journal of Australia|September 16, 1991
Profiles of antibacterial drug use in Australia and trends from 1987 to 1989. A report from the Drug Utilization Subcommittee of the Pharmaceutical Benefits Advisory CommitteeD J Birkett, A S Mitchell, A Godeck, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1990
Tolbutamide hydroxylation by human, rabbit and rat liver microsomes and by purified forms of cytochrome P-450M E Veronese, M E McManus, P Laupattarakasem, et al.
Biomedical Mass Spectrometry|May 1, 1979
Plasma quantitation of warfarin and warfarin alcohol by gas chromatography chemical ionization mass spectrometry in patients on warfarin maintenance therapyA M Duffield, P H Duffield, D J Birkett, et al.
Pageof 13

Showing results (81-90 of 127) with videos related to

Sort By:
Pageof 13
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1995
Human hepatic cytochrome P450 2C9 catalyzes the rate-limiting pathway of torsemide metabolismJ O Miners, D L Rees, L Valente, et al.
The Medical Journal of Australia|December 1, 1979
Availability of schedule 3 preparations from community pharmaciesJ W Ilic, P R Saloniklis, J Hughes, et al.
British Journal of Clinical Pharmacology|January 3, 2001
The xenobiotic inhibitor profile of cytochrome P4502C8C E Ong, S Coulter, D J Birkett, et al.
British Journal of Clinical Pharmacology|February 1, 1997
1-Methylxanthine derived from caffeine as a pharmacodynamic probe of oxypurinol effectD J Birkett, J O Miners, L Valente, et al.
Biochemical Pharmacology|December 3, 1993
Validation of 4-nitrophenol as an in vitro substrate probe for human liver CYP2E1 using cDNA expression and microsomal kinetic techniquesW Tassaneeyakul, M E Veronese, D J Birkett, et al.
British Journal of Clinical Pharmacology|August 1, 1986
Influence of gender and oral contraceptive steroids on the metabolism of salicylic acid and acetylsalicylic acidJ O Miners, N Grgurinovich, A G Whitehead, et al.
Biochemistry|October 17, 1989
Structural and functional analysis of NADPH-cytochrome P-450 reductase from human liver: complete sequence of human enzyme and NADPH-binding sitesM Haniu, M E McManus, D J Birkett, et al.
The Medical Journal of Australia|September 16, 1991
Profiles of antibacterial drug use in Australia and trends from 1987 to 1989. A report from the Drug Utilization Subcommittee of the Pharmaceutical Benefits Advisory CommitteeD J Birkett, A S Mitchell, A Godeck, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1990
Tolbutamide hydroxylation by human, rabbit and rat liver microsomes and by purified forms of cytochrome P-450M E Veronese, M E McManus, P Laupattarakasem, et al.
Biomedical Mass Spectrometry|May 1, 1979
Plasma quantitation of warfarin and warfarin alcohol by gas chromatography chemical ionization mass spectrometry in patients on warfarin maintenance therapyA M Duffield, P H Duffield, D J Birkett, et al.
Pageof 13